company background image
THRN logo

Thorne HealthTech NasdaqGS:THRN Stock Report

Last Price

US$10.19

Market Cap

US$550.6m

7D

0.1%

1Y

128.5%

Updated

18 Oct, 2023

Data

Company Financials +

Thorne HealthTech, Inc.

NasdaqGS:THRN Stock Report

Market Cap: US$550.6m

THRN Stock Overview

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally.

THRN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance4/6
Financial Health5/6
Dividends0/6

Thorne HealthTech, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Thorne HealthTech
Historical stock prices
Current Share PriceUS$10.19
52 Week HighUS$10.20
52 Week LowUS$3.41
Beta0.82
1 Month Change0.39%
3 Month Change93.36%
1 Year Change128.48%
3 Year Changen/a
5 Year Changen/a
Change since IPO34.97%

Recent News & Updates

Recent updates

Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Aug 12
Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar

Jun 07
Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar

Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist

Dec 17
Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist

Thorne HealthTech Grows But Faces Macro Headwinds

Sep 09

Thorne HealthTech's blood collection device OneDraw gets clearance in Japan

Aug 23

Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised

Aug 09

Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies

Jun 05

Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality

Mar 23
Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality

Thorne HealthTech: Good Potential At A Low Price

Jan 11

Shareholder Returns

THRNUS Personal ProductsUS Market
7D0.1%0.9%0.4%
1Y128.5%-25.5%28.8%

Return vs Industry: THRN exceeded the US Personal Products industry which returned -31.9% over the past year.

Return vs Market: THRN exceeded the US Market which returned 14.1% over the past year.

Price Volatility

Is THRN's price volatile compared to industry and market?
THRN volatility
THRN Average Weekly Movement12.1%
Personal Products Industry Average Movement9.6%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: THRN's share price has been volatile over the past 3 months.

Volatility Over Time: THRN's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1984544Paul Jacobsonhttps://www.thorne.com

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual’s health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health.

Thorne HealthTech, Inc. Fundamentals Summary

How do Thorne HealthTech's earnings and revenue compare to its market cap?
THRN fundamental statistics
Market capUS$550.63m
Earnings (TTM)US$20.33m
Revenue (TTM)US$258.01m

27.1x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
THRN income statement (TTM)
RevenueUS$258.01m
Cost of RevenueUS$127.58m
Gross ProfitUS$130.43m
Other ExpensesUS$110.10m
EarningsUS$20.33m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.38
Gross Margin50.55%
Net Profit Margin7.88%
Debt/Equity Ratio16.1%

How did THRN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.